Table 2.
Natural Antioxidants | Animal Models | Intervention Period | Species/ Gender |
Age at BP Determination (week) | Beneficial Effects | Ref. |
---|---|---|---|---|---|---|
Amino acids | ||||||
3% L-glycine in chow | Maternal low protein diet | Pregnancy and lactation | Wistar/M | 4 | Prevented hypertension | [70] |
0.25% L-citrulline in drinking water | Maternal STZ-induced diabetes | Pregnancy and lactation | SD/M | 12 | Prevented hypertension | [31] |
0.25% L-citrulline in drinking water | Maternal L-NAME exposure |
Pregnancy and lactation | SD/M | 12 | Prevented hypertension | [71] |
0.25% L-citrulline in drinking water | Prenatal dexamethasone exposure | Pregnancy and lactation | SD/M | 12 | Prevented hypertension | [72] |
0.25% L-citrulline in drinking water | Genetic hypertension | 2 weeks before until 6 weeks after birth | SHR/M & F | 50 | Prevented hypertension | [73] |
3% L-taurine in drinking water |
Maternal highsugar diet |
Pregnancy and lactation | SD/F | 8 | Prevented hypertension | [74] |
3% L-taurine in drinking water |
Maternal STZ-induced diabetes | Pregnancy and lactation | Wistar/M & F | 16 | Prevented hypertension | [75] |
L-tryptophan 200 mg/kg BW/day via oral gavage | Maternal adenosine-induced CKD | Pregnancy | SD/M | 12 | Prevented hypertension | [76] |
BCAA-supplemented diets | Maternal caloric Restriction |
Pregnancy | SD/M | 16 | Prevented hypertension | [77] |
Amino acids plus vitamins | ||||||
L-arginine, L-taurine, Vitamins C and E | Genetic hypertension | 2 weeks before until 8 weeks after birth | SHR/M& F | 9 | Prevented hypertension | [78] |
L-arginine, L-taurine, Vitamins C and E | Genetic hypertension | 2 weeks before until 4 weeks after birth | FHH/M & F | 36 | Prevented hypertension | [79] |
L-arginine, L-taurine, Vitamins C and E | Genetic hypertension | 2 weeks before until 8 weeks after birth | SHR/M & F | 50 | Prevented hypertension | [80] |
Vitamins | ||||||
Vitamin C, E, folic acid and selenium | Maternal caloric Restriction |
Pregnancy | Wistar/ M & F |
16 | Prevented hypertension | [81] |
Vitamin C 350 mg/kg/day i.p. daily | Prenatal LPS Exposure |
Gestational day 8 to 14 | SD/M | 12 | Prevented hypertension | [82] |
5 mg/kg folate in chow | Maternal low protein diet |
Pregnancy | Wistar/M | 15 | Prevented hypertension | [83] |
α-tocopherol 350 mg/kg/day via gavage | Prenatal LPS Exposure |
Gestational day 13 to 20 | Wistar/M | 28 | Prevented hypertension | [84] |
Melatonin | ||||||
0.01% melatonin in drinking water | Maternal caloric restriction | Pregnancy and lactation | SD/M | 12 | Prevented hypertension | [30] |
0.01% melatonin in drinking water | Maternal methyl-donor diet | Pregnancy and lactation | SD/M | 12 | Attenuated hypertension | [38] |
0.01% melatonin in drinking water | Maternal constant light exposure | Pregnancy and lactation | SD/M | 12 | Prevented hypertension | [85] |
0.01% melatonin in drinking water | Maternal L-NAME exposure | Pregnancy and lactation | SD/M | 12 | Prevented hypertension | [86] |
0.01% melatonin in drinking water | Maternal high-fructose diet | Pregnancy and lactation | SD/M | 12 | Prevented hypertension | [87] |
0.01% melatonin in drinking water | Maternal high-fructose diet plus post-weaning high-salt diet | Pregnancy and lactation | SD/M | 12 | Attenuated hypertension | [88] |
0.01% melatonin in drinking water | Prenatal dexamethasone exposure | Pregnancy and lactation | SD/M | 16 | Prevented hypertension | [89] |
0.01% melatonin in drinking water | Prenatal dexamethasone exposure plus post-weaning high-fat diet | Pregnancy and lactation | SD/M | 16 | Prevented hypertension | [90] |
Melatonin 10 mg/kg BW/day in drinking water | Genetic hypertension model | Pregnancy | SHR/M | 16 | Prevented hypertension | [91] |
Resveratrol | ||||||
50 mg/L resveratrol in drinking water | Maternal plus post-weaning high-fructose diet | Pregnancy and lactation | SD rat/M | 12 | Prevented hypertension | [92] |
50 mg/L resveratrol in drinking water | Maternal bisphenol A exposure and high-fat diet | Pregnancy and lactation | SD rat/M | 16 | Prevented hypertension | [44] |
0.05% resveratrol in drinking water | Maternal TCDD and dexamethasone exposures | Pregnancy and lactation | SD rat/M | 16 | Prevented hypertension | [45] |
50 mg/L resveratrol in drinking water | Maternal L-NAME plus postnatal high-fat diet | Pregnancy and lactation | SD rat/M | 16 | Attenuated hypertension |
[93] |
4 g/kg diet resveratrol | Genetic hypertension model | Pregnancy and lactation | SHR/M & F | 20 | Prevented hypertension | [94] |
N-acetylcysteine (NAC) | ||||||
1% NAC in drinking water | Suramin-induced preeclampsia |
Pregnancy and lactation | SD/M | 12 | Prevented hypertension | [34] |
1% NAC in drinking water | Maternal L-NAME exposure |
Pregnancy and lactation | SD/M | 12 | Prevented hypertension | [84] |
1% NAC in drinking water | Prenatal dexamethasone and postnatal high-fat diet |
Pregnancy and lactation | SD/M | 12 | Prevented hypertension | [95] |
1% NAC in drinking water | Genetic hypertension model | Pregnancy and lactation | SHR/M | 12 | Prevented hypertension | [96] |
NAC 500 mg/kg/day in drinking water | Maternal nicotine exposure |
Gestational day 4 to postnatal day 10 | SD/M | 32 | Prevented hypertension | [32] |
Others | ||||||
Conjugated linoleic acid | Maternal high-fat diet | Pregnancy and lactation | SD/M | 18 | Attenuated hypertension | [97] |
Fish oil | Maternal low protein diet | Pregnancy and 10 days after birth | Wistar/M &F | 25 | Prevented hypertension | [98] |
Studies tabulated according to types of natural antioxidant, animal models and age at measure. STZ = streptozotocin. L-NAME = NG-nitro-L-arginine-methyl ester. CKD = chronic kidney disease. BCAA = branched-chain amino acid. LPS = lipopolysaccharide. TCDD = 2,3,7,8-tetrachlorodibenzo-p-dioxin. SD = Sprague-Dawley rat. SHR = spontaneously hypertensive rat. FHH = Fawn hooded hypertensive rat. M = male. F = female.